Glycopezil represents a novel class of antibiotic agent currently under research. It possesses promising activity against a comprehensive spectrum of bacterial pathogens, including those resistant to existing antibiotic therapies. The process of action continues to be investigated, but initial results suggest that Glycopezil interacts with bacteria